246 related articles for article (PubMed ID: 29400024)
1. E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.
Choi YJ; Lee A; Kim TJ; Jin HT; Seo YB; Park JS; Lee SJ
J Gynecol Oncol; 2018 May; 29(3):e38. PubMed ID: 29400024
[TBL] [Abstract][Full Text] [Related]
2. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
[No Abstract] [Full Text] [Related]
3. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
[TBL] [Abstract][Full Text] [Related]
4. Performance of the HPV-16 L1 methylation assay and HPV E6/E7 mRNA test for the detection of squamous intraepithelial lesions in cervical cytological samples.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Rong S; Okunieff P; Zhang L; Li X
J Virol Methods; 2015 Nov; 224():35-41. PubMed ID: 26297960
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.
Lee SJ; Lee AW; Kang CS; Park JS; Park DC; Ki EY; Lee KH; Yoon JH; Hur SY; Kim TJ
Int J Med Sci; 2014; 11(1):80-6. PubMed ID: 24396289
[TBL] [Abstract][Full Text] [Related]
6. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.
Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M
Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661
[TBL] [Abstract][Full Text] [Related]
7. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer.
Wu Z; Yu L; Lei X; Qin Y; Zhang X; Chen W; Qiao Y
J Clin Virol; 2018 Nov; 108():6-11. PubMed ID: 30196013
[TBL] [Abstract][Full Text] [Related]
8. HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More.
Chen L; Dong B; Gao H; Xue H; Pan D; Sun P
J Inflamm Res; 2020; 13():813-821. PubMed ID: 33149654
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.
Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E
Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
Cao L; Sun PL; Yao M; Chen S; Gao H
Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP
Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761
[TBL] [Abstract][Full Text] [Related]
13. [The role of human papillomavirus 16 early genes E2 and E6 and heterogeneous nuclear ribonucleoprotein E2 in cervical carcinogenesis and their interaction effect].
Gao W; Ding L; Song ZC; Feng MJ; Liu CL; Li XX; Song L; Lyu YJ; Wang JT
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jan; 54(1):92-98. PubMed ID: 31914575
[No Abstract] [Full Text] [Related]
14. A proper triage for detecting women with high-risk human papillomavirus genotypes other than HPV16/18.
Wang JJ; Lyu LP; Hu QW; Wan ZQ; Dong J; Pan M; Shen WW; Zhang S
Eur J Obstet Gynecol Reprod Biol; 2017 Dec; 219():113-118. PubMed ID: 29101837
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1.
Choi YS; Kang WD; Kim SM; Choi YD; Nam JH; Park CS; Choi HS
Int J Gynecol Cancer; 2010 Feb; 20(2):288-93. PubMed ID: 20134272
[TBL] [Abstract][Full Text] [Related]
16. High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV-positive women with minor cytological abnormalities.
Norman I; Hjerpe A; Andersson S
Oncol Rep; 2013 Aug; 30(2):695-700. PubMed ID: 23756570
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.
Cerasuolo A; Annunziata C; Tortora M; Starita N; Stellato G; Greggi S; Maglione MG; Ionna F; Losito S; Botti G; Buonaguro L; Buonaguro FM; Tornesello ML
Oncotarget; 2017 May; 8(21):34070-34081. PubMed ID: 28423662
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.
Saunier M; Monnier-Benoit S; Mauny F; Dalstein V; Briolat J; Riethmuller D; Kantelip B; Schwarz E; Mougin C; Prétet JL
J Clin Microbiol; 2008 Nov; 46(11):3678-85. PubMed ID: 18799702
[TBL] [Abstract][Full Text] [Related]
19. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
20. HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma.
Xue Y; Bellanger S; Zhang W; Lim D; Low J; Lunny D; Thierry F
Cancer Res; 2010 Jul; 70(13):5316-25. PubMed ID: 20530671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
